Mutaguchi et al. revealed that inactivation of IGFBP7 occurs through CpG methylation, and the tumor-suppressive activity of IGFBP7 relies on the induction of programmed cell death in an IGF-I independent manner in cancer of the prostatic gland (101). Here, IGFBP7 is linked to prostate cancer.